We are live on ! Find out more
AVDL

Avadel Pharmaceuticals
AVDL

Delisted

AVDL was delisted on the 11th of February, 2026.

Back to rankings

71 hedge funds and large institutions have $332M invested in Avadel Pharmaceuticals in 2014 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 21 increasing their positions, 25 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

137% more call options, than puts

Call options by funds: $1.45M | Put options by funds: $611K

117% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 6

11% more funds holding

Funds holding: 64 → 71 (+7)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

3% less capital invested

Capital invested by funds: $342M → $332M (-$10.3M)

16% less repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 25

Holders
71
Holders Change
+7
Holders Change %
+10.94%
% of All Funds
2.06%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
13
Increased
21
Reduced
25
Closed
6
Calls
$1.45M
Puts
$611K
Net Calls
+$840K
Net Calls Change
+$3.4M

Top Buyers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$6.64M
2
PC
PointState Capital
New York
+$5.75M
3
KCM
Kennedy Capital Management
Missouri
+$4.42M
4
TI
Turner Investments
Pennsylvania
+$2.71M
5
Morgan Stanley
Morgan Stanley
New York
+$2.19M

Top Sellers

Rank Fund Capital Flow
1
CCM
Consonance Capital Management
New York
-$9.45M
2
BC
Broadfin Capital
New York
-$3.77M
3
PA
Perceptive Advisors
New York
-$2.73M
4
Millennium Management
Millennium Management
New York
-$2.21M
5
Jennison Associates
Jennison Associates
New York
-$1.55M
Name Holding Trade Value Shares
Change 		Change in
Stake
WSA
26
Wall Street Associates
California
$1.73M +$1.74M +120,852 New
Marshall Wace
27
Marshall Wace
United Kingdom
$1.64M +$1.64M +114,327 New
California Public Employees Retirement System
28
California Public Employees Retirement System
California
$1.6M – – –
Comerica Bank
29
Comerica Bank
Texas
$930K +$934K +64,977 New
Neuberger Berman Group
30
Neuberger Berman Group
New York
$905K -$239K -16,600 -21%
ACM
31
Atika Capital Management
New York
$887K +$71.9K +5,000 +9%
IAM
32
Iridian Asset Management
Connecticut
$834K -$22.3K -1,550 -3%
ICAP
33
Independence Capital Asset Partners
Colorado
$780K +$356K +24,750 +83%
U
34
UBS
Switzerland
$775K -$10.4K -721 -1%
IMS
35
Index Management Solutions
Pennsylvania
$749K -$351K -24,454 -32%
TSW
36
Thompson Siegel & Walmsley
Virginia
$708K -$31.6K -2,200 -4%
COPPSERS
37
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$656K +$493K +34,316 +298%
Janney Montgomery Scott
38
Janney Montgomery Scott
Pennsylvania
$594K +$237K +16,500 +66%
EVM
39
Eaton Vance Management
Massachusetts
$497K – – –
BCM
40
Bourgeon Capital Management
Connecticut
$446K -$52.4K -3,649 -10%
State Street
41
State Street
Massachusetts
$444K +$446K +31,008 New
Stifel Financial
42
Stifel Financial
Missouri
$373K +$1.22K +85 +0.3%
DADC
43
D.A. Davidson & Co
Montana
$372K -$28.7K -2,000 -7%
AC
44
Ascend Capital
California
$333K +$125K +8,670 +59%
Credit Agricole
45
Credit Agricole
France
$301K -$7.19K -500 -2%
TD Asset Management
46
TD Asset Management
Ontario, Canada
$255K +$256K +17,800 New
CS
47
Credit Suisse
Switzerland
$218K +$11.1K +769 +5%
Susquehanna International Group
48
Susquehanna International Group
Pennsylvania
$197K -$842K -58,578 -81%
US Bancorp
49
US Bancorp
Minnesota
$179K – – –
DWA
50
Dorsey Wright & Associates
California
$156K -$11.6K -809 -7%
1
2
3 4

AVDL Hedge Fund Activity: Q3 2014 in Review

71 of the 3,448 institutional investors tracked by Wall St. Rank reported a position in Avadel Pharmaceuticals (AVDL) for Q3 2014, worth a combined $332M — down 3% from $342M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new AVDL positions and 6 closed out — a net gain of 7 holders — while 21 added to existing stakes and 25 trimmed.

The largest buyer was T. Rowe Price Associates, opening a new position worth an estimated $6.64M. The largest seller was Consonance Capital Management, exiting entirely with an estimated $9.45M sold.

  • 71 institutional investors held Avadel Pharmaceuticals (AVDL) as of Q3 2014, up from 64 in Q2 2014.
  • Funds reported $332M of Avadel Pharmaceuticals stock for Q3 2014, down 3% quarter-over-quarter.
  • 13 funds opened new Avadel Pharmaceuticals positions in Q3 2014 and 6 closed out, a net change of +7 holders.
  • The largest Avadel Pharmaceuticals buyer in Q3 2014 was T. Rowe Price Associates, an estimated $6.64M added.
  • The largest Avadel Pharmaceuticals seller in Q3 2014 was Consonance Capital Management, an estimated $9.45M sold.

Based on aggregated 13F filings for Q3 2014.